Back to answers

Answer

What is AI deal health?

AI deal health is a current read on whether a deal is strong, weak, or slipping. Data Parrot scores deal health from CRM activity, emails, calls, meetings, deal progression, purchase intent, and engagement patterns, then shows the reason behind the score so revenue teams can decide where to focus.

What does AI deal health show?

AI deal health should explain the deal, not only label it. In Data Parrot, Deal Health includes health status, progress status, purchase intent, chance of winning, why the team may win or lose, recent change context, and suggested next actions.

  • Which deals look strong, weak, or stalled
  • Why the score changed
  • What signals are driving risk or momentum
  • Which deals need manager attention before the forecast meeting

Who uses AI deal health?

VP Sales, sales managers, RevOps, and founders use AI deal health when the CRM record does not give enough context. The goal is a faster, more objective read on deal quality before a review, forecast call, or coaching conversation.

How is AI deal health different from CRM probability?

CRM probability often depends on stage rules or manual rep updates. AI deal health reads the activity around the deal and explains the score with supporting signals. The score is useful because the team can see the evidence behind it.

Frequently asked questions.

What signals affect AI deal health?

+

Data Parrot uses deal progression, buyer engagement, CRM activity, meetings, emails, calls, purchase intent, chance of winning, and recent changes to produce deal health signals.

Does AI deal health update as the deal changes?

+

Yes. Data Parrot updates deal health as activity, engagement, stage movement, and deal context change.

Can AI deal health help with coaching?

+

Yes. Deal Health gives managers the score, reasoning, and next-best actions they need to focus coaching on the deals that need attention.

Review your revenue data with Data Parrot.

See how Data Parrot turns CRM activity into deal health, forecast risk, pipeline movement, and review prep.